
Prescription Required

Authentic Product

India's Leading Generic Pharmacy

Secure Payment
HEMLIBRA 150MG/ML INJECTION
By ROCHE PRODUCTS INDIA PRIVATE LIMITED
MRP
₹
294392
₹276523
6.07 % OFF
Check Delivery
--

Composition
Product Details
About HEMLIBRA 150MG/ML INJECTION
- HEMLIBRA 150MG/ML INJECTION contains the active ingredient Emicizumab. It belongs to a group of medicines known as monoclonal antibodies. This injection is used to treat patients with hemophilia A. It is specifically for people with hemophilia A who have developed Factor VIII inhibitors (where the body's immune system attacks standard hemophilia treatment). It's also prescribed for people with severe hemophilia A who have not yet developed Factor VIII inhibitors (meaning their natural Factor VIII blood level is less than 1%).
- Hemophilia A is a lifelong condition that is passed down through families. It happens because there isn't enough Factor VIII, a crucial protein needed for blood to clot properly. Without enough Factor VIII, people with hemophilia A can experience frequent and sometimes severe bleeding episodes, which can be painful and damaging. HEMLIBRA 150MG/ML INJECTION helps to bridge the gap caused by the missing Factor VIII, promoting blood clotting even when Factor VIII is low or treatments are being blocked by inhibitors. By helping the blood clot more effectively, this medicine aims to prevent bleeding or significantly reduce how often bleeding episodes happen in people with this condition.
- You should not use HEMLIBRA 150MG/ML INJECTION if you have a known allergy to Emicizumab or any of the other ingredients listed in the medicine. Before starting treatment, it is very important to tell your doctor about all other medicines you are currently taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements. Also, inform your doctor if you have any other medical conditions. While this medicine is designed to prevent bleeding, you must contact your physician immediately if you experience unusual bleeding after taking it. This medicine is suitable for patients of all age groups. When giving the injection, avoid areas on the skin that are red, bruised, tender, hard, or have moles or scars.
Safety Advice for HEMLIBRA 150MG/ML INJECTION
BreastFeeding
UnsafeBreastfeeding is not recommended in patients taking HEMLIBRA 150MG/ML INJECTION because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
Driving
SafeHEMLIBRA 150MG/ML INJECTION does not affect your ability to drive and operate heavy machinery. Inform your physician if you face any symptoms that alter your concentration.
Liver Function
SafeIt is safe to administer HEMLIBRA 150MG/ML INJECTION in patients with liver problems. No dose adjustments are needed for mild to moderate impairment. However, Inform your physician if you have any liver diseases before initiating the treatment.

Lungs
Consult a DoctorIt is unknown whether HEMLIBRA 150MG/ML INJECTION can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
Pregnancy
UnsafeDo not take HEMLIBRA 150MG/ML INJECTION if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting pregnancy, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for 6 months after the last dose.
Dosage of HEMLIBRA 150MG/ML INJECTION
- HEMLIBRA 150MG/ML INJECTION is given as an injection directly under the skin, which is medically referred to as a subcutaneous injection. Before you administer this medicine yourself, a qualified doctor, nurse, or another trained healthcare professional will provide thorough instructions and demonstrate the correct technique. It is extremely important that you do not try to inject HEMLIBRA until you have received this training and feel completely comfortable and confident in your ability to do so safely. The specific dose of HEMLIBRA prescribed for you will be decided by your physician. This dosage is carefully determined based on your individual medical condition, its severity, and your body weight. The approved and recommended areas on your body for giving this injection are the lower part of your stomach (abdomen), the outer area of your upper arms, or the front part of your thighs. It is vital that you only use these designated sites for your injections. To ensure proper absorption of the medicine and to avoid potential skin irritation or complications, you must always rotate your injection site. This means that for each new injection, you should select a different spot within the recommended areas. Avoid injecting into the exact same location as your previous injection. Planning your injection sites in advance can be helpful. Always inspect the HEMLIBRA solution before use. Make sure the injection site is clean. After administering the injection, dispose of the used syringe and needle safely in a puncture-resistant container, as instructed by your healthcare provider. Following these steps helps ensure the medicine is given effectively and safely.
How to store HEMLIBRA 150MG/ML INJECTION?
- Keep HEMLIBRA 150MG INJ 1ML away from the reach of children and pets.
- Store HEMLIBRA 150MG INJ 1ML in a refrigerator (2 - 8°C). Do not freeze.
Benefits of HEMLIBRA 150MG/ML INJECTION
- HEMLIBRA 150MG/ML INJECTION works by connecting two important factors in your blood, activated factor IX and factor X, to help your body form blood clots more effectively.
- It helps restore the function of missing activated factor VIII, which is necessary for the natural blood clotting process to work correctly and stop bleeding.
- Unlike standard factor VIII treatments, HEMLIBRA is structured differently, meaning it is not affected by factor VIII inhibitors (antibodies your body might develop that block other treatments).
- This makes HEMLIBRA a suitable option for people with hemophilia A who have developed inhibitors, helping them achieve better control over bleeding episodes and improving their ability to form clots when needed.
How to use HEMLIBRA 150MG/ML INJECTION
- HEMLIBRA 150MG/ML INJECTION is given as an injection just under your skin. This method is called subcutaneous administration. It is very important that a doctor, nurse, or other trained healthcare professional shows you exactly how to give the injection safely *before* you try it yourself. Do not attempt to administer the medicine on your own until you have received complete training and feel confident. Your physician is responsible for deciding the correct dose of the injection for you, based on your specific medical condition and its severity.
- The best and recommended areas on your body to give the injection are the front of your waist (specifically the lower abdomen area), the upper outer part of your arms, or the front of your thighs. You should only use these recommended places for your injections.
- It is crucial to use a different injection area within the recommended sites each time you give yourself HEMLIBRA 150MG/ML INJECTION. Always rotate your injection sites to help prevent skin issues like hardness or irritation. Before injecting, ensure the site is clean as per your healthcare provider's instructions. Avoid injecting into skin that is bruised, tender, red, hard, or has scars. Follow the specific injection technique (like pinching the skin and injecting slowly) taught during your training. Remember to dispose of all used needles and syringes properly in a puncture-resistant container. If you have any questions about injecting, always ask your doctor or nurse.
FAQs
Can HEMLIBRA 150MG/ML INJECTION be self-administered at home?

Yes, HEMLIBRA 150MG/ML INJECTION can be self-administered at home after proper training and instructions from a healthcare professional. However, the decision to self-administer should be made in consultation with the healthcare team.
Can HEMLIBRA 150MG/ML INJECTION be used in pediatric patients with hemophilia?

Yes, HEMLIBRA 150MG/ML INJECTION is approved for use in pediatric patients with hemophilia A. The dosage and administration may vary depending on the age and weight of the child, and it should be prescribed and monitored by a healthcare professional.
Is HEMLIBRA 150MG/ML INJECTION suitable for all types of hemophilia?

HEMLIBRA 150MG/ML INJECTION is specifically designed for the treatment of hemophilia A, which is caused by a deficiency of clotting factor VIII. It is not intended for other types of hemophilia, such as hemophilia B.
How is HEMLIBRA 150MG/ML INJECTION administered?

HEMLIBRA 150MG/ML INJECTION is administered as a subcutaneous injection. Generally, it is given once a week, every two weeks, or every four weeks, depending on the treatment plan determined by the healthcare provider. The frequency of the administration depends on your disease condition and other factors.
What should I inform the physician before starting the treatment with HEMLIBRA 150MG/ML INJECTION?

Before you start using HEMLIBRA 150MG/ML INJECTION, talk to your doctor and carefully follow their instructions on when to use a bypassing agent and the dose and schedule you should use. It increases the ability of your blood to clot. Therefore, the dose of bypassing agent required may be lower than the dose you used before starting HEMLIBRA.
What are the interactions of HEMLIBRA 150MG/ML INJECTION with other drugs?

Please inform your doctor about all medications you are taking, as HEMLIBRA 150MG/ML INJECTION may interact with other drugs.
How should HEMLIBRA 150MG/ML INJECTION be administered?

This medicine is given as a shot under your skin. It is usually injected into the upper outer arms, thighs, or stomach. Use a different body area each time you give yourself a shot. Keep track of where you give each shot to make sure you rotate body areas. Do not inject into skin areas that are tender, red, bruised, hard, or not intact, or into areas with moles or scars. Use a new needle and syringe each time you inject your medicine. Women should use an effective form of birth control to keep from getting pregnant. Tell your doctor right away if you think you have become pregnant. Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.
What is the active ingredient in HEMLIBRA 150MG/ML INJECTION?

The active ingredient in HEMLIBRA 150MG/ML INJECTION is EMICIZUMAB.
What ailments/conditions is HEMLIBRA 150MG/ML INJECTION prescribed for?

HEMLIBRA 150MG/ML INJECTION is primarily prescribed for the treatment of blood disorders, specifically hemophilia A.
How does HEMLIBRA 150MG/ML INJECTION work in treating blood disorders?

HEMLIBRA 150MG/ML INJECTION helps bridge the function of missing clotting factor VIII in people with hemophilia A, helping to reduce bleeding episodes.
Ratings & Review
Genuine handling person
Naresh Jangid
•
Reviewed on 30-03-2024
(5/5)
Good series, satisfied customer
Sameer Jadhav
•
Reviewed on 06-01-2024
(5/5)
Good staff and all generic medicines are available.👍
DALPAT PARMAR
•
Reviewed on 19-01-2024
(5/5)
Medkart is a healthcare platform that educates people in India about generic medicines. its very Good work, keep it up.
jayswal sachin
•
Reviewed on 18-01-2024
(5/5)
Often get medicines at a cheaper rate. Almost 50% cheaper
vivaan shah
•
Reviewed on 10-06-2023
(5/5)
Marketer / Manufacturer Details
ROCHE PRODUCTS INDIA PRIVATE LIMITED
Country of Origin -
India

MRP
₹
294392
₹276523
6.07 % OFF
Quick Links
Disclaimer
Medkart's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, medicines, generic alternatives, all possible side effects, drug interactions, warnings, alerts, lab tests, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
India's most trusted generic medicine pharmacy.
10 Lakh+
Happy customers
35000+
Pin-codes Covered
75 Lakh+
Orders Delivered
Authentic Products
All WHO-GMP Certified Medicines
Download the app for free
©2025 Medkart Pharmacy. All Rights Reserved